OrbiMed Genesis GP LLC
- SEC CIK
- 0001808744
In the past year, 3 open-market purchase filings worth $59.9M and 3 sale filings worth $52.4M.
Current role at each company
- ETRA Electra Therapeutics, Inc.Director, 10% Owneras of Sep 23, 2026
- BRVE Braveheart Bio, Inc.Director, 10% Owneras of Aug 11, 2026
- ELVN Enliven Therapeutics, Inc.10% Owneras of Jun 24, 2026
- STTK Shattuck Labs, Inc.Directoras of Jun 15, 2026
- QTTB Q32 Bio Inc.Director, 10% Owneras of Jun 1, 2026
Show 17 more companies
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- IMA ImageneBio, Inc.Directoras of Apr 16, 2026
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- KROS Keros Therapeutics, Inc.Directoras of Dec 18, 2025
- CMPX Compass Therapeutics, Inc.Director, 10% Owneras of Apr 11, 2025
- EWTX Edgewise Therapeutics, Inc.Director, 10% Owneras of Apr 4, 2025
- IRON Disc Medicine, Inc.Directoras of Mar 26, 2025
- MBX MBX Biosciences, Inc.Director, 10% Owneras of Feb 19, 2025
- SCPH scPharmaceuticals Inc.10% Owneras of Aug 15, 2024
- TERN Terns Pharmaceuticals, Inc.Director, 10% Owneras of Jul 17, 2024
- ALPN Alpine Immune Sciences, Inc.Directoras of May 20, 2024
- KNTE Kinnate Biopharma Inc.Director, 10% Owneras of Apr 5, 2024
- THRX Theseus Pharmaceuticals, Inc.Director, 10% Owneras of Feb 14, 2024
- PMVP PMV Pharmaceuticals, Inc.10% Owneras of Nov 24, 2023
- DMRA Damora Therapeutics, Inc.10% Owneras of Aug 17, 2023
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
- JANX Janux Therapeutics, Inc.Directoras of Dec 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $59.9M
- 3 filings
- Sold
- $52.4M
- 3 filings
- Net
- +$7.56M
- Bought minus sold
- Companies
- 4
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Genesis GP LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ETRA Electra Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)5:29 PM ET | Sep 21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +313.8%1.76M after | 2 lots |
BRVE Braveheart Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)5:27 PM ET | Aug 7 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.94M | $18.00 | +$34.9M | New position273.3K after | 2 lots |
ELVN Enliven Therapeutics, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing)7:19 PM ET | Jun 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −860.1K | $45.36 | −$39.0M | −11.6%6.56M after | 4 lots |
| Jun 17, 2026 (view filing)7:45 PM ET | Jun 15 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −281.4K | $45.02 | −$12.7M | −3.7%7.39M after | 2 lots |
| May 20, 2024 (view filing)5:00 PM ET | May 16 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −1.03M | $22.14 | −$22.9M | −11.9%7.66M after | 2 lotsDuplicate filing |
STTK Shattuck Labs, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing)6:12 PM ET | Jun 11 | 4 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +1.25M | – | – | –5.30M after | Derivative2 lotsDuplicate filing |
| Sep 2, 2025 (view filing)9:52 PM ET | Aug 25 | 8 daysLate | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +6.31M | $0.8677 | +$5.47M | New position1.05M after | 2 lots |
| Sep 2, 2025 (view filing)9:52 PM ET | Aug 25 | 8 daysLate | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +30.6M | – | – | –3.07M after | Derivative4 lotsDuplicate filing |
QTTB Q32 Bio Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 (view filing)9:13 PM ET | May 28 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.88M | $8.00 | +$15.0M | New position625.0K after | 2 lotsDuplicate filing |
PRLD Prelude Therapeutics Inc
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 (view filing)6:48 PM ET | Apr 21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +2.82M | $4.44 | +$12.5M | New position1.13M after | 2 lotsDuplicate filing |
IMA ImageneBio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 (view filing)7:23 PM ET | Apr 14 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +721.3K | – | – | –384.7K after | Derivative2 lotsDuplicate filing |
| Jun 24, 2022 (view filing)5:39 PM ET | Jun 22-24 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | −252.2K | $4.47 | −$1.13M | −10.7%2.10M after | 4 lotsDuplicate filing |
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
CMPX Compass Therapeutics, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 (view filing)7:24 PM ET | Apr 9 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −3.57M | $1.59 | −$5.68M | −100.0%0 after | Duplicate filing |
| Nov 10, 2022 (view filing)4:44 PM ET | Nov 8 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +402.0K | $3.21 | +$1.29M | +2.7%15.2M after | Duplicate filing |
| May 13, 2022 (view filing)5:45 PM ET | May 11-13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +192.5K | $2.18 | +$420.5K | +1.3%14.8M after | 3 lotsDuplicate filing |
| May 10, 2022 (view filing)6:21 PM ET | May 6-10 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +125.4K | $1.57 | +$197.3K | +0.9%14.6M after | 3 lotsDuplicate filing |
| Nov 8, 2021 (view filing)9:06 PM ET | Nov 4 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +5.36M | $3.50 | +$18.8M | New position3.57M after | 2 lotsDuplicate filing |
EWTX Edgewise Therapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 (view filing)7:33 PM ET | Apr 3 | 1 day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +496.8K | $20.13 | +$10.0M | New position443.8K after | 2 lotsDuplicate filing |
| Jan 25, 2024 (view filing)4:28 PM ET | Jan 23 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +454.5K | $11.00 | +$5.00M | +3.3%14.4M after | Duplicate filing |
| Sep 16, 2022 (view filing)4:31 PM ET | Sep 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +484.5K | $10.32 | +$5.00M | +3.6%14.0M after | Duplicate filing |
| May 20, 2022 (view filing)4:38 PM ET | May 18 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +138.0K | $7.21 | +$995.0K | +1.0%13.5M after | Duplicate filing |
IRON Disc Medicine, Inc.
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 (view filing)7:00 PM ET | Mar 24 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −5.74K | $54.11 | −$310.5K | −3.0%186.5K after | 3 lotsDuplicate filing |
| Mar 21, 2025 (view filing)8:00 PM ET | Mar 19-21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −52.4K | $54.02 | −$2.83M | −21.9%187.3K after | 9 lotsDuplicate filing |
| Mar 12, 2025 (view filing)9:34 PM ET | Mar 10-12 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −312.4K | $54.31 | −$17.0M | −61.7%194.2K after | 15 lotsDuplicate filing |
| Jun 20, 2024 (view filing)5:19 PM ET | Jun 17 | 3 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +83.3K | $36.00 | +$3.00M | +54.8%235.4K after | 3 lotsDuplicate filing |
| Dec 20, 2023 (view filing)6:28 PM ET | Dec 18 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −1.72K | $59.24 | −$102.1K | −100.0%0 after | Duplicate filing |
| Dec 15, 2023 (view filing)6:04 PM ET | Dec 14 | 1 day | OrbiMed Advisors LLC and 3 othersDirector | SSale | −433.2K | $56.75 | −$24.6M | −65.9%224.4K after | 3 lotsDuplicate filing |
| Dec 14, 2023 (view filing)5:44 PM ET | Dec 12-14 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −134.2K | $58.88 | −$7.90M | −15.6%727.8K after | 8 lotsDuplicate filing |
| Feb 17, 2023 (view filing)4:43 PM ET | Feb 15 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +108.7K | $23.00 | +$2.50M | +57.1%299.2K after | 3 lotsDuplicate filing |
MBX MBX Biosciences, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing)5:52 PM ET | Feb 14-18 | 5 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +190.7K | $10.60 | +$2.02M | +34.2%747.9K after | 4 lotsDuplicate filing |
| Sep 17, 2024 (view filing)8:13 PM ET | Sep 16 | 1 day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $16.00 | +$12.0M | New position653.8K after | 2 lotsDuplicate filing |
KROS Keros Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing)5:01 PM ET | Aug 13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −250.0K | $44.01 | −$11.0M | −67.7%119.5K after | 2 lotsDuplicate filing |
SCPH scPharmaceuticals Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing)4:51 PM ET | Aug 13 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +500.0K | $4.00 | +$2.00M | New position252.9K after | 2 lots |
| Nov 29, 2022 (view filing)4:36 PM ET | Nov 25 | 4 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +762.4K | $5.25 | +$4.00M | +16.7%5.33M after |
TERN Terns Pharmaceuticals, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 (view filing)8:48 PM ET | Jul 15-16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | SSale | −56.2K | $10.00 | −$561.6K | −6.9%755.6K after | 6 lots10b5-1Duplicate filing |
| Dec 28, 2022 (view filing)5:57 PM ET | Dec 23 | 5 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +137.9K | $7.25 | +$1.00M | +2.9%4.88M after | Duplicate filing |
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +3.69M | $2.42 | +$8.93M | New position762.4K after | 3 lotsDuplicate filing |
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +310.0K | – | – | –64.0K after | Derivative3 lotsDuplicate filing |
ALPN Alpine Immune Sciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 (view filing)4:18 PM ET | Dec 27-28 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −1.55M | $18.54 | −$28.7M | −85.4%264.3K after | 6 lotsDuplicate filing |
| Sep 21, 2021 (view filing)6:42 PM ET | Sep 17 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.01M | $9.40 | +$9.50M | New position425.5K after | 2 lotsDuplicate filing |
PMVP PMV Pharmaceuticals, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2023 (view filing)4:38 PM ET | Nov 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −87.8K | $2.23 | −$195.8K | −100.0%0 after | |
| May 31, 2022 (view filing)4:36 PM ET | May 26 | 5 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −26.3K | $15.93 | −$418.2K | −23.0%87.8K after | |
| Mar 31, 2022 (view filing)5:30 PM ET | Mar 29-31 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −474.5K | $21.63 | −$10.3M | −100.0%0 after | 3 lots |
DMRA Damora Therapeutics, Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing)4:40 PM ET | Aug 15 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −822.7K | $0.75 | −$617.0K | −35.3%1.51M after | 3 lots |
| Aug 2, 2023 (view filing)5:05 PM ET | Jul 31 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −209.4K | $3.00 | −$628.2K | −9.0%2.11M after | 3 lots |
| Jul 27, 2023 (view filing)4:28 PM ET | Jul 25 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −39.2K | $2.92 | −$114.5K | −1.7%2.26M after | 3 lots |
| Jul 17, 2023 (view filing)4:13 PM ET | Jul 13 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −194.7K | $2.40 | −$467.3K | −7.8%2.29M after | 3 lots |
| Apr 17, 2023 (view filing)5:28 PM ET | Apr 13-17 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −68.5K | $1.87 | −$128.3K | −2.8%2.42M after | 9 lots |
| Apr 12, 2023 (view filing)6:44 PM ET | Apr 10-12 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −67.5K | $1.80 | −$121.4K | −2.7%2.46M after | 9 lots |
| Apr 7, 2023 (view filing)4:42 PM ET | Apr 5-6 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −102.6K | $2.16 | −$222.0K | −3.9%2.51M after | 6 lots |
THRX Theseus Pharmaceuticals, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 (view filing)4:15 PM ET | Jul 17 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +479.9K | $3.05 | +$1.46M | +281.2%650.6K after | 2 lotsDuplicate filing |
| Nov 9, 2022 (view filing)4:25 PM ET | Nov 7 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +192.0K | $5.21 | +$1.00M | +1.2%16.7M after | Duplicate filing |
| Jan 21, 2022 (view filing)7:18 PM ET | Jan 19-21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +158.4K | $9.97 | +$1.58M | +1.0%16.5M after | 3 lotsDuplicate filing |
| Jan 13, 2022 (view filing)7:18 PM ET | Jan 11-13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +44.7K | $9.90 | +$442.8K | +0.3%16.4M after | 4 lotsDuplicate filing |
| Oct 14, 2021 (view filing)5:00 PM ET | Oct 12 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +625.0K | $16.00 | +$10.0M | New position499.1K after | 2 lotsDuplicate filing |
KNTE Kinnate Biopharma Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 (view filing)5:22 PM ET | May 4-5 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.46M | $2.80 | +$4.09M | New position1.37M after | 5 lotsDuplicate filing |
| May 2, 2023 (view filing)9:34 PM ET | Apr 28-May 2 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.41M | $2.61 | +$3.67M | New position794.4K after | 9 lotsDuplicate filing |
| Feb 15, 2022 (view filing)9:42 PM ET | Feb 11-15 | 4 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +195.7K | $10.17 | +$1.99M | +5.9%3.51M after | 4 lotsDuplicate filing |
1 more company has matching trades:
- JANX3 trades